Business

Novo Nordisk: A Comeback Story In The World’s Fastest-Growing Drug Market (TSX:NOVO:CA)

Published

on

This article was written by

The Edson Spencer Professor of Strategy and Technological Leadership at the University of Minnesota Carlson School of Management Alfred Marcus’ most recent book, Comeback: Can Great Companies Rise Again is available on Amazon. He is host of the popular New Books Network Podcast On the Cusp: Between Strategy and Ethics. and the author, co-author, or editor of more than 20 books including Strategic for Managing Uncertainty and Demography and the Global Business Environment (with M. Islam) as well as many academic articles

Analyst’s Disclosure: I/we have a beneficial long position in the shares of NOVO:CA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I also own Lilly.

Advertisement

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version